Jagsonpal Pharmaceuticals : Appointment

JAGSONPAL PHARMACEUTICALS LIMITED

Regd. Office. T-210 J, Shahpur Jat, New Delhi - 110 049 (INDIA)

Fax [phone], Phone: [phone]

Email:[e-mail];[e-mail]

	CIN No. L74899DL1978PLC009181
July 16, 2022
The Department of Corporate	Services-	National Stock Exchange of India Ltd
Listing		Exchange Plaza, C-1, Block G,
BSE Ltd,		Bandra Kurla Complex,
Phiroze Jeejeebhoy Towers,		Bandra (E)
Dalal Street		Mumbai - 400 051
Mumbai-400 001		Symbol: JAGSNPHARM
Scrip Code: 507789

Dear Madam / Sir,

Sub: Intimation under Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations").

Ref: Change in Statutory Auditors

We wish to inform you that the Board of Directors, based on the recommendation of the Audit Committee, have considered and recommended the appointment of M/s. Walter Chandiok & Co LLP, Chartered Accountants (Firm No. 001076N/ N500013) as the Statutory Auditor of the Company for a period of 5 (Five) years from the conclusion of the 43rd Annual General Meeting till conclusion of 48th Annual General Meeting, in place of existing Statutory Auditors, M/s H.L. Bansal & Co, Chartered Accountants, whose term shall end at the conclusion of the ensuing Annual General Meeting.

The appointment will be subject to the approval of the shareholders of the Company at the ensuing 43rd Annual General Meeting of the Company.

We request you to take the above on record.

For JAGSONPAL PHARMACEUTICALS LIMITED

Nandita Singh

Company Secretary cum Compliance Officer